We are live on ! Find out more
S

SignatureFD Portfolio holdings

AUM $7.49B
1-Year Est. Return 24.82%
This Fund
S&P 500
This Quarter Est. Return
-1.74%
1 Year Est. Return
+24.82%
3 Year Est. Return
+73.56%
5 Year Est. Return
+79.97%
10 Year Est. Return
+256.52%
AUM
$6.53B
AUM Growth
-$23.2M
Cap. Flow
+$184M
Cap. Flow %
2.82%
Top 10 Hldgs %
56.23%
Holding
3,611
New
211
Increased
1,773
Reduced
820
Closed
149

Sector Composition

Rank Sector Weight
1 Technology 9.77%
2 Financials 4.62%
3 Consumer Discretionary 3.39%
4 Communication Services 2.71%
5 Industrials 2.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SBCF icon
2876
Seacoast Banking Corp of Florida
SBCF
$3.36B
$3.76K ﹤0.01%
124
-123
-50% -$3.97K
IHAK icon
2877
iShares Cybersecurity and Tech ETF
IHAK
$1B
$3.71K ﹤0.01%
+85
New +$3.88K
CHCO icon
2878
City Holding Co
CHCO
$2.05B
$3.71K ﹤0.01%
31
-35
-53% -$4.27K
XERS icon
2879
Xeris Biopharma Holdings
XERS
$1.39B
$3.66K ﹤0.01%
631
-89
-12% -$590
SPH icon
2880
Suburban Propane Partners
SPH
$1.24B
$3.64K ﹤0.01%
185
+35
+23% +$698
HTB
2881
HomeTrust Bancshares
HTB
$860M
$3.63K ﹤0.01%
85
MMI icon
2882
Marcus & Millichap
MMI
$1.16B
$3.62K ﹤0.01%
136
-169
-55% -$4.45K
TH icon
2883
Target Hospitality
TH
$1.51B
$3.6K ﹤0.01%
388
SIDU icon
2884
Sidus Space
SIDU
$171M
$3.6K ﹤0.01%
+1,550
New +$4.22K
STOK icon
2885
Stoke Therapeutics
STOK
$1.8B
$3.58K ﹤0.01%
110
+27
+33% +$885
BLSH
2886
Bullish
BLSH
$3.3B
$3.57K ﹤0.01%
100
LNTH icon
2887
Lantheus
LNTH
$6.49B
$3.56K ﹤0.01%
47
+16
+52% +$1.15K
ACLX
2888
DELISTED
Arcellx
ACLX
$3.56K ﹤0.01%
31
-5
-14% -$441
EDIT icon
2889
Editas Medicine
EDIT
$396M
$3.56K ﹤0.01%
1,440
BHVN icon
2890
Biohaven
BHVN
$2.03B
$3.55K ﹤0.01%
420
-88
-17% -$963
NAGE
2891
Niagen Bioscience
NAGE
$271M
$3.55K ﹤0.01%
+804
New +$4.34K
DJT icon
2892
Trump Media & Technology Group
DJT
$2.73B
$3.54K ﹤0.01%
382
+32
+9% +$368
ANIP icon
2893
ANI Pharmaceuticals
ANIP
$1.8B
$3.54K ﹤0.01%
46
AMLX icon
2894
Amylyx Pharmaceuticals
AMLX
$2.26B
$3.53K ﹤0.01%
+254
New +$3.57K
SYRE icon
2895
Spyre Therapeutics
SYRE
$8.54B
$3.53K ﹤0.01%
70
UNF icon
2896
Unifirst Corp
UNF
$5.3B
$3.52K ﹤0.01%
14
+7
+100% +$1.61K
ELA icon
2897
Envela
ELA
$563M
$3.52K ﹤0.01%
+211
New +$2.9K
FXH icon
2898
First Trust Health Care AlphaDEX Fund
FXH
$1.04B
$3.51K ﹤0.01%
32
AURA icon
2899
Aura Biosciences
AURA
$725M
$3.49K ﹤0.01%
522
+176
+51% +$1.01K
BOXX icon
2900
Alpha Architect 1-3 Month Box ETF
BOXX
$13.1B
$3.49K ﹤0.01%
30

Similar funds

SignatureFD's Q1 2026 Portfolio in Review

As of Q1 2026, SignatureFD held 3,611 positions worth $6.53B, down 0.35% from $6.55B the previous quarter. Its ten largest holdings account for 56% of the portfolio.

SignatureFD's Q1 2026 filing shows 211 new, 1,773 increased, 820 reduced and 149 closed positions. Its largest new stake was iShares 0-1 Year Treasury Bond ETF: 7,706 shares worth $851K. The largest sale was JPMorgan US Quality Factor ETF, an estimated $314M.

By sector, the portfolio is most concentrated in Technology at 9.8% of assets, down from 10% a quarter earlier, followed by Financials and Consumer Discretionary.

  • SignatureFD's largest Q1 2026 buy was iShares 0-1 Year Treasury Bond ETF: 7,706 shares worth $851K.
  • SignatureFD added most to Vanguard Morningstar Small-Cap ETF in Q1 2026, an estimated $240M increase.
  • SignatureFD's biggest Q1 2026 reduction was JPMorgan US Quality Factor ETF, cutting an estimated $314M.
  • SignatureFD fully exited AstraZeneca in Q1 2026, selling an estimated $6.05M.
  • SignatureFD's ten largest holdings make up 56% of its $6.53B portfolio in Q1 2026.
  • SignatureFD opened 211 new positions and closed 149 in Q1 2026.
  • SignatureFD's portfolio value fell 0.35% quarter-over-quarter to $6.53B.

Based on SignatureFD's 13F filing for Q1 2026, filed 7 Apr 2026.